ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW 904.00
+19.00 (2.15%)
At close: Mar 26, 2026
KOSDAQ:034940 Revenue
In the year 2025, ChoA Pharmaceutical Co., LTD. had annual revenue of 59.31B KRW, down -5.40%. ChoA Pharmaceutical Co., LTD. had revenue of 15.82B in the quarter ending December 31, 2025, a decrease of -6.99%.
Revenue
59.31B
Revenue Growth
-5.40%
P/S Ratio
0.48
Revenue / Employee
220.49M
Employees
269
Market Cap
28.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.31B | -3.38B | -5.40% |
| Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
| Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
| Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
| Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 95.37B |
| GeneBioTech Co. ,Ltd | 92.28B |
| Korean Drug | 62.51B |
| WooGene B&G | 54.77B |
| Seoul Pharma | 52.43B |
| Union Korea Pharm | 33.83B |
| Daesung Microbiological Labs. | 25.99B |
| BIFIDO | 19.68B |